摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氯-7-甲氧基-2-(三氟甲基)喹啉 | 401567-80-4

中文名称
4-氯-7-甲氧基-2-(三氟甲基)喹啉
中文别名
——
英文名称
4-Chloro-7-methoxy-2-(trifluoromethyl)quinoline
英文别名
——
4-氯-7-甲氧基-2-(三氟甲基)喹啉化学式
CAS
401567-80-4
化学式
C11H7ClF3NO
mdl
——
分子量
261.63
InChiKey
XXQNTJYGCQHTEQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    22.1
  • 氢给体数:
    0
  • 氢受体数:
    5

文献信息

  • Proline derivatives and use thereof as drugs
    申请人:Kitajima Hiroshi
    公开号:US20050245538A1
    公开(公告)日:2005-11-03
    The present invention aims at providing compounds having therapeutic effects due to a DPP-IV inhibitory action, and satisfactory as pharmaceutical products. The present inventors have found that derivatives having a substituent introduced into the γ-position of proline represented by the formula (I) wherein each symbol is as defined in the specification, have a potent DPP-IV inhibitory activity, and completed the present invention by increasing the stability.
    本发明旨在提供具有治疗效果的化合物,其作用是通过DPP-IV的抑制作用,并且作为药物产品具有令人满意的效果。本发明人发现,在丙氨酸的γ位上引入取代基的衍生物具有强效的DPP-IV抑制活性,并通过增加稳定性完成了本发明。
  • Proline derivatives and the use thereof as drugs
    申请人:——
    公开号:US20040106655A1
    公开(公告)日:2004-06-03
    The present invention aims at providing compounds having therapeutic effects due to a DPP-IV inhibitory action, and satisfactory as pharmaceutical products. The present inventors have found that derivatives having a substituent introduced into the &ggr;-position of proline represented by the formula (I) 1 wherein each symbol is as defined in the specification, have a potent DPP-IV inhibitory activity, and completed the present invention by increasing the stability.
    本发明旨在提供具有治疗作用的化合物,由于DPP-IV抑制作用而具有满意的药物产品。本发明人发现,具有引入取代基的脯氨酸γ-位置的衍生物,其化学式为(I)1,其中每个符号如规范中所定义,具有强效的DPP-IV抑制活性,并通过增加稳定性完成了本发明。
  • PROLINE DERIVATIVES AND USE THEREOF AS DRUGS
    申请人:Mitsubishi Tanabe Pharma Corporation
    公开号:EP1308439B1
    公开(公告)日:2008-10-15
  • US7060722B2
    申请人:——
    公开号:US7060722B2
    公开(公告)日:2006-06-13
  • US7074794B2
    申请人:——
    公开号:US7074794B2
    公开(公告)日:2006-07-11
查看更多